title: Pharmaceutical approval update.
abstract: Simeprevir (Olysio) for chronic hepatitis C infection; coagulation Factor XIII A-subunit (recombinant) (Tretten) for bleeding prevention in congenital Factor XIII A-subunit deficiency; and umeclidinium and vilanterol inhalation powder (Anoro Ellipta) for chronic obstructive pulmonary disease.
authors.forename: Marvin M
authors.initials: MM
authors.lastname: Goldenberg